Local reactions are typically monitored through clinical trials and post-marketing surveillance programs. Participants in clinical trials are closely observed and asked to report any adverse events, including local reactions. Post-marketing surveillance involves collecting data from healthcare providers and patients after a vaccine or medication has been approved for use.
